![Tom Frohlich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Frohlich
Vorstandsvorsitzender bei
JADE BIOSCIENCES, INC.
Profil
Tom Frohlich was the founder of Chinook Therapeutics, Inc., founded in 2019, where the title held was Chief Operating Officer from 2021 to 2023.
Current jobs include Chief Executive Officer & Director at Jade Biosciences, Inc. (United States) starting in 2024, and Chief Executive Officer & Director at Jade Biosciences, Inc. starting in 2025.
Former jobs include Vice President-Business Development at Arbutus Biopharma Corp.
from 2016 to 2018, Senior Vice President-Business Development at Inception Sciences, Inc. in 2018, and Entrepreneur-in-Residence at Versant Ventures Canada Ltd. Education includes an MBA from the University of Oxford in 2007 and an undergraduate degree from the University of Victoria in 1998.
Aktive Positionen von Tom Frohlich
| Unternehmen | Position | Beginn |
|---|---|---|
| JADE BIOSCIENCES, INC. | Vorstandsvorsitzender | 28.04.2025 |
Ehemalige bekannte Positionen von Tom Frohlich
| Unternehmen | Position | Ende |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Gründer | 01.10.2023 |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Corporate Officer/Principal | 01.12.2018 |
| ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | 01.03.2018 |
Versant Ventures Canada Ltd.
 Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | - |
Ausbildung von Tom Frohlich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Victoria
 University of Victoria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
Versant Ventures Canada Ltd.
Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Wählen Sie MarketScreener 
